Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

PLSE stock hub

Pulse Biosciences, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

PLSEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.3B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

PLSE

In the news

Latest news · PLSE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-80.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-48.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All PLSE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

182

Groups with data

Currency

USD

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001625101
Company name	Pulse Biosciences, Inc.
Country	United States
Country code	US
Cusip	74587B101
Employees	116
Employees Change	41%
Employees Change Percent	54.67
Enterprise value	$1.2B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Instruments & Supplies
IPO Date	2016-05-18
Isin	US74587B1017
Last refreshed	2026-05-10
Market cap	$1.3B
Market cap category	Small-Cap
Price	$19.08
Price currency	USD
Rev Per Employee	6,474.14x
Sector	Healthcare
Sic	3841
Symbol	PLSE
Website	https://www.pulsebiosciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.73%
EV Sales Forward	249.49x
EV/Sales	1,651.89x
P/B ratio	19.63x
P/S ratio	1,733.33x
PS Forward	261.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-21.04%
Gross Profit	$-158,000
Net Income	$-74.6M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-9,929.03%
Profit Per Employee	$-642,819
ROA	-45.03
Roa5y	-51.24
ROCE	-107.8
ROE	-80.72
Roe5y	-181.9
ROIC	-48.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	14.33%
Cagr3y	36.29%
Cagr5y	2.16%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth Years	0x
Revenue Growth3 Y	43.15x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$81.6M
Cash	$68.3M
Current Assets	$71.1M
Current Liabilities	$9.8M
Debt	$7.2M
Debt Equity	$0.11
Equity	$66.3M
Liabilities	$15.3M
Long Term Assets	$10.5M
Long Term Liabilities	$5.5M
Net Cash	$61.2M
Net Cash By Market Cap	$4.7
Net Cash Growth	-44.75%
Net Debt Equity	$-0.92
Tangible Book Value	$63.1M
Tangible Book Value Per Share	$0.92
WACC	13.14

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.26
Inventory Turnover	7.7
Net Working Capital	$-5.4M
Quick ratio	6.99
Working Capital	$61.3M
Working Capital Turnover	$0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-11.03%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	14.32%
200-day SMA	17.29
3Y total return	153.22%
50-day SMA	20.82
50-day SMA vs 200-day SMA	50over200
5Y total return	11.25%
All Time High	45.82
All Time High Change	-58.36%
All Time High Date	2021-02-08
All Time Low	1.18
All Time Low Change	1,516.95%
All Time Low Date	2022-08-30
ATR	1.42
Beta	1.63
Beta1y	0.87
Beta2y	1.57
Ch YTD	38.97
High	19.67
High52	26.3
High52 Date	2026-02-11
High52ch	-27.45%
Low	18.66
Low52	12.56
Low52 Date	2025-11-20
Low52ch	51.91%
Ma50ch	-8.34%
Price vs 200-day SMA	10.37%
RSI	41.38
RSI Monthly	56.84
RSI Weekly	50.84
Sharpe ratio	0.48x
Sortino ratio	1.01
Total Return	-11.03%
Tr YTD	38.97
Tr1m	-4.41%
Tr1w	-8.4%
Tr3m	-8.05%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Buy
Earnings EPS Estimate	$-0.24
Earnings Revenue Estimate	420,000x
Operating Income	$-77.5M
Operating margin	-10,313.6
Price target	$22
Price Target Change	$15.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	18,071,374%
Float Percent	26.49%
Shares Insiders	72.59%
Shares Institutions	9.03%
Shares Out	68,225,067
Shares Qo Q	0.3%
Shares Yo Y	11.03%
Short Float	16.09%
Short Ratio	11.36
Short Shares	4.26

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	245,500.75x
Bv Per Share	0.97
Ch1m	-4.41
Ch1w	-8.4
Ch1y	14.32
Ch3m	-8.05
Ch3y	153.2
Ch5y	11.25
Ch6m	23.42
Change	-2.6%
Change From Open	-3
Close	19.59
Days Gap	0.41
Depreciation Amortization	1,055,750
Dollar Volume	3,848,168.9
Earnings Date	2026-05-04
Earnings Time	bmo
EBIT	$-77.5M
EBITDA	$-76.4M
EPS	$-1.1
F Score	0
Fiscal Year End	December
Founded	2,014
Goodwill	2,791,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-19
Ma150	17.72
Ma150ch	7.71%
Ma20	21.26
Ma20ch	-10.27%
Next Earnings Date	2026-08-11
Open	19.67
Optionable	Yes
Position In Range	41.58
Post Close	19.08
Postmarket Change Percent	0.1
Postmarket Price	$19.1
Ppne	6,718,000
Price Date	2026-05-08
Ptbv Ratio	20.63
Relative Volume	0.82x
Revenue	751,000x
Tr6m	23.42%
Us State	Florida
Volume	201,686
Z Score	33.38

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does PLSE pay a dividend?

Capital-return profile for this ticker.

Performance

PLSE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns PLSE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+9.0%

Float: +26.5% of shares outstanding

Insider ownership

+72.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

PLSE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.4

Neutral momentum band

Price vs 200-day MA

+10.4%

50/200-day relationship not available

Beta (5Y)

1.63

More volatile than the market

Sharpe ratio

0.48

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About PLSE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current PLSE stock rating?

Pulse Biosciences, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full PLSE analysis?

The full report lives at /stocks/PLSE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for PLSE?

The latest report frames PLSE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the PLSE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.